The Role of JAK/STAT Signaling Pathway and Its Downstream Influencing Factors in the Treatment of Atherosclerosis

Atherosclerosis is now widely considered to be a chronic inflammatory disease, with increasing evidence suggesting that lipid alone is not the main factor contributing to its development. Rather, atherosclerotic plaques contain a significant amount of inflammatory cells, characterized by the accumul...

Full description

Saved in:
Bibliographic Details
Published inJournal of cardiovascular pharmacology and therapeutics Vol. 29; p. 10742484241248046
Main Authors Zhang, Xin, Chen, Suwen, Yin, Guoliang, Liang, Pengpeng, Feng, Yanan, Yu, Wenfei, Meng, Decheng, Liu, Hongshuai, Zhang, Fengxia
Format Journal Article
LanguageEnglish
Published Los Angeles, CA SAGE Publications 01.01.2024
SAGE Publishing
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Atherosclerosis is now widely considered to be a chronic inflammatory disease, with increasing evidence suggesting that lipid alone is not the main factor contributing to its development. Rather, atherosclerotic plaques contain a significant amount of inflammatory cells, characterized by the accumulation of monocytes and lymphocytes on the vessel wall. This suggests that inflammation may play a crucial role in the occurrence and progression of atherosclerosis. As research deepens, other pathological factors have also been found to influence the development of the disease. The Janus kinase/signal transducer and activator of transcription (JAK/STAT) pathway is a recently discovered target of inflammation that has gained attention in recent years. Numerous studies have provided evidence for the causal role of this pathway in atherosclerosis, and its downstream signaling factors play a significant role in this process. This brief review aims to explore the crucial role of the JAK/STAT pathway and its representative downstream signaling factors in the development of atherosclerosis. It provides a new theoretical basis for clinically affecting the development of atherosclerosis by interfering with the JAK/STAT signaling pathway.
AbstractList Atherosclerosis is now widely considered to be a chronic inflammatory disease, with increasing evidence suggesting that lipid alone is not the main factor contributing to its development. Rather, atherosclerotic plaques contain a significant amount of inflammatory cells, characterized by the accumulation of monocytes and lymphocytes on the vessel wall. This suggests that inflammation may play a crucial role in the occurrence and progression of atherosclerosis. As research deepens, other pathological factors have also been found to influence the development of the disease. The Janus kinase/signal transducer and activator of transcription (JAK/STAT) pathway is a recently discovered target of inflammation that has gained attention in recent years. Numerous studies have provided evidence for the causal role of this pathway in atherosclerosis, and its downstream signaling factors play a significant role in this process. This brief review aims to explore the crucial role of the JAK/STAT pathway and its representative downstream signaling factors in the development of atherosclerosis. It provides a new theoretical basis for clinically affecting the development of atherosclerosis by interfering with the JAK/STAT signaling pathway.Atherosclerosis is now widely considered to be a chronic inflammatory disease, with increasing evidence suggesting that lipid alone is not the main factor contributing to its development. Rather, atherosclerotic plaques contain a significant amount of inflammatory cells, characterized by the accumulation of monocytes and lymphocytes on the vessel wall. This suggests that inflammation may play a crucial role in the occurrence and progression of atherosclerosis. As research deepens, other pathological factors have also been found to influence the development of the disease. The Janus kinase/signal transducer and activator of transcription (JAK/STAT) pathway is a recently discovered target of inflammation that has gained attention in recent years. Numerous studies have provided evidence for the causal role of this pathway in atherosclerosis, and its downstream signaling factors play a significant role in this process. This brief review aims to explore the crucial role of the JAK/STAT pathway and its representative downstream signaling factors in the development of atherosclerosis. It provides a new theoretical basis for clinically affecting the development of atherosclerosis by interfering with the JAK/STAT signaling pathway.
Atherosclerosis is now widely considered to be a chronic inflammatory disease, with increasing evidence suggesting that lipid alone is not the main factor contributing to its development. Rather, atherosclerotic plaques contain a significant amount of inflammatory cells, characterized by the accumulation of monocytes and lymphocytes on the vessel wall. This suggests that inflammation may play a crucial role in the occurrence and progression of atherosclerosis. As research deepens, other pathological factors have also been found to influence the development of the disease. The Janus kinase/signal transducer and activator of transcription (JAK/STAT) pathway is a recently discovered target of inflammation that has gained attention in recent years. Numerous studies have provided evidence for the causal role of this pathway in atherosclerosis, and its downstream signaling factors play a significant role in this process. This brief review aims to explore the crucial role of the JAK/STAT pathway and its representative downstream signaling factors in the development of atherosclerosis. It provides a new theoretical basis for clinically affecting the development of atherosclerosis by interfering with the JAK/STAT signaling pathway.
Author Zhang, Xin
Zhang, Fengxia
Liang, Pengpeng
Feng, Yanan
Liu, Hongshuai
Yu, Wenfei
Chen, Suwen
Yin, Guoliang
Meng, Decheng
Author_xml – sequence: 1
  givenname: Xin
  surname: Zhang
  fullname: Zhang, Xin
  email: fxzhang0987@163.com
– sequence: 2
  givenname: Suwen
  surname: Chen
  fullname: Chen, Suwen
– sequence: 3
  givenname: Guoliang
  surname: Yin
  fullname: Yin, Guoliang
– sequence: 4
  givenname: Pengpeng
  surname: Liang
  fullname: Liang, Pengpeng
– sequence: 5
  givenname: Yanan
  surname: Feng
  fullname: Feng, Yanan
– sequence: 6
  givenname: Wenfei
  surname: Yu
  fullname: Yu, Wenfei
– sequence: 7
  givenname: Decheng
  surname: Meng
  fullname: Meng, Decheng
– sequence: 8
  givenname: Hongshuai
  surname: Liu
  fullname: Liu, Hongshuai
– sequence: 9
  givenname: Fengxia
  orcidid: 0000-0002-9574-8155
  surname: Zhang
  fullname: Zhang, Fengxia
  email: fxzhang0987@163.com
BackLink https://www.ncbi.nlm.nih.gov/pubmed/38656132$$D View this record in MEDLINE/PubMed
BookMark eNp9kUtv3CAUhVGVqnm0P6CbimU3TsA8bC9HadJOGqlV464RhusJIw8kgBXl3xd3ki5SKQu46PKdAzr3GB344AGhj5ScUto0Z5Q0vOZtWbQUwuUbdEQ7TipOGD8o53JfLcAhOk5pS0hpi-4dOmStFJKy-gjd97eAf4UJcBjx1er72U2_6vGN23g9Ob_BP3W-fdCPWHuL1znhL-HBpxxB7_Daj9MM3izYpTY5xISdx7kY9gXIO_B5cV2VTgzJTMvu0nv0dtRTgg9P9QT9vrzoz79V1z--rs9X15XhvMuVacFKK3jXARuaUbSMUALCcDHYFriUtmmAFZbZlnSNBeBgzUCJNoxoMbATtN772qC36i66nY6PKmin_jZC3CgdsyvfUqNsTSepqaWhJSDQQktBgRpeM1Y3XfH6vPe6i-F-hpTVziUD06Q9hDkpVrIXtKWUFfTTEzoPO7D_Hn6OvADNHjAljhRhVMZlnV3wOWo3KUrUMlz133CLkr5QPpu_pjnda5LegNqGOZbBplcEfwBHcbD5
CitedBy_id crossref_primary_10_3389_fimmu_2024_1437821
crossref_primary_10_3390_ph17111426
crossref_primary_10_1016_j_jds_2024_09_021
crossref_primary_10_1007_s12035_025_04834_4
crossref_primary_10_1016_j_obmed_2025_100585
crossref_primary_10_3390_cells14030153
Cites_doi 10.1038/s41572-019-0106-z
10.1016/j.intimp.2021.108117
10.1186/1476-9255-8-34
10.1084/jem.20090545
10.1016/j.cell.2022.09.023
10.1042/bj20030407
10.1093/cvr/cvy007
10.1016/j.abb.2012.09.007
10.1007/978-981-15-4272-5_18
10.1038/s41569-019-0227-9
10.1126/science.8197455
10.7150/ijbs.46651
10.1016/bs.apcsb.2019.11.002
10.1016/j.tcm.2021.02.001
10.4049/jimmunol.1101228
10.1016/j.biopha.2021.112358
10.3390/ijms21020418
10.1126/scitranslmed.aax0481
10.1080/15384101.2022.2066295
10.1073/pnas.84.8.2396
10.1016/j.vph.2005.08.021
10.1016/j.cell.2022.04.004
10.1016/S0140-6736(21)00438-4
10.1161/CIRCULATIONAHA.120.052604
10.1111/jcmm.16003
10.3389/fimmu.2021.714943
10.1016/j.jacc.2005.09.068
10.1186/s13046-019-1428-0
10.1016/j.biopha.2022.112781
10.1038/s42255-019-0102-3
10.1002/1097-0029(20000801)50:3<184::AID-JEMT2>3.0.CO;2-H
10.1111/j.1600-065X.2008.00698.x
10.1016/j.bbrc.2006.04.010
10.1038/s41467-023-36614-w
10.1016/j.exger.2004.04.011
10.1016/j.intimp.2022.109095
10.1038/aps.2015.87
10.1111/j.0959-9673.2003.00363.x
10.1016/j.phymed.2022.154385
10.1093/eurheartj/ehab447
10.1016/S0002-9440(10)64820-1
10.1016/j.cca.2017.11.005
10.1371/journal.pone.0051608
10.1007/s13277-015-3534-8
10.1016/j.tips.2021.11.001
10.3892/ijmm.2013.1323
10.1101/cshperspect.a016295
10.3389/fimmu.2022.954706
10.1038/s41420-022-00906-9
10.1016/0092-8674(93)90508-N
10.1038/s41392-021-00507-5
10.1097/00024382-200202000-00001
10.1161/CIRCRESAHA.118.311362
10.1016/j.bbrc.2017.06.020
10.1089/ars.2013.5371
10.1161/01.CIR.0000148135.08582.97
10.3390/ijms20133328
10.1002/mc.2940080402
10.1016/j.semcancer.2013.05.008
10.1136/annrheumdis-2020-219012
10.1016/j.intimp.2020.106210
10.1080/01926230701320337
10.1038/sj.onc.1209281
10.1016/j.biopha.2022.113775
10.1101/cshperspect.a021873
10.18632/aging.103034
10.1161/ATVBAHA.108.173781
10.1074/jbc.M704267200
10.1161/CIRCRESAHA.121.319077
10.1093/eurheartj/ehy310
10.1111/jcmm.12923
10.1038/nature15514
10.1161/CIRCRESAHA.122.320877
10.1016/j.cardiores.2007.02.022
10.18632/aging.100934
10.1038/s41392-021-00791-1
10.1007/s40265-017-0701-9
10.1007/s10753-015-0135-z
10.1186/s40164-022-00283-0
10.1038/nature22393
10.1136/annrheumdis-2013-203756
10.1161/ATVBAHA.114.304144
10.3389/fimmu.2018.01135
ContentType Journal Article
Copyright The Author(s) 2024
Copyright_xml – notice: The Author(s) 2024
DBID AFRWT
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOA
DOI 10.1177/10742484241248046
DatabaseName Sage Journals GOLD Open Access 2024
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DOAJ: Directory of Open Access Journals
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic

MEDLINE

CrossRef
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 4
  dbid: AFRWT
  name: Sage Journals GOLD Open Access 2024
  url: http://journals.sagepub.com/
  sourceTypes: Publisher
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Pharmacy, Therapeutics, & Pharmacology
EISSN 1940-4034
ExternalDocumentID oai_doaj_org_article_f68c961c26c1459ea5a651e1c4233279
38656132
10_1177_10742484241248046
10.1177_10742484241248046
Genre Journal Article
Review
GroupedDBID ---
-TM
.2F
.2G
01A
0R~
18M
29K
31S
31Y
36B
4.4
53G
54M
5GY
5VS
AABMB
AACKU
AADUE
AAGGD
AAJIQ
AAJOX
AAJPV
AANSI
AAPEO
AAQDB
AAQGT
AAQXH
AARDL
AARIX
AASGM
AAWTL
AAXOT
AAYTG
AAZBJ
ABAWP
ABCCA
ABDWY
ABEIX
ABFWQ
ABHKI
ABJIS
ABJNI
ABKRH
ABPGX
ABQKF
ABQXT
ABRHV
ABVFX
ABVVC
ABXGC
ABYTW
ACARO
ACBMB
ACDSZ
ACDXX
ACFMA
ACFYK
ACGBL
ACGFS
ACLHI
ACOFE
ACROE
ACRPL
ADBBV
ADEBD
ADEIA
ADMPF
ADNBR
ADNMO
ADOGD
ADPDF
ADSTG
ADTBJ
ADUKL
ADYCS
ADZZY
AECVZ
AENEX
AEQLS
AERKM
AEUHG
AEWDL
AEXFG
AEXNY
AFCOW
AFEET
AFKBI
AFKRG
AFRWT
AFUIA
AFWMB
AGNHF
AGQPQ
AHHFK
AIGRN
AJABX
AJEFB
AJMMQ
AJSCY
AJUZI
ALMA_UNASSIGNED_HOLDINGS
ARTOV
ASPBG
AUTPY
AUVAJ
AVWKF
AYAKG
AZFZN
B8M
B8O
B93
BDDNI
BKSCU
BSEHC
CAG
CBRKF
CDWPY
CFDXU
COF
CORYS
CQQTX
CS3
CUTAK
D-I
DC-
DC.
DC0
DD-
DD0
DE-
DOPDO
DU5
D~Y
EBD
EBS
EJD
EMB
EMOBN
F5P
FEDTE
GROUPED_DOAJ
GROUPED_SAGE_PREMIER_JOURNAL_COLLECTION
H13
HF~
HVGLF
HZ~
J8X
K.F
K.J
LXL
LXN
MK0
N9A
O9-
OK1
OVD
OVEED
P.B
Q1R
Q7K
Q7R
Q7X
Q82
ROL
RWL
S01
SAUOL
SCDPB
SCNPE
SFB
SFC
SFN
SGA
SGP
SGX
SQCSI
SV3
TAE
TEORI
ZONMY
ZPPRI
ZRKOI
ZSSAH
AAYXX
ACHEB
CITATION
31X
AADTT
AAMGE
AATBZ
ABHQH
ACGZU
ACSBE
ACSIQ
ACTQU
ACUIR
AEUIJ
AEWHI
AIOMO
B8Z
CGR
CUY
CVF
DV7
ECM
EIF
M4V
NPM
SFK
SFT
SGV
SPJ
7X8
ID FETCH-LOGICAL-c449t-c8ed6d5499e3b7f583010e5c45bd8e466d77e3c443d8097dee4edcb10ac30a5b3
IEDL.DBID AFRWT
ISSN 1074-2484
1940-4034
IngestDate Wed Aug 27 01:19:51 EDT 2025
Fri Jul 11 16:10:05 EDT 2025
Wed Feb 19 01:58:52 EST 2025
Thu Apr 24 23:08:56 EDT 2025
Tue Jul 01 05:25:19 EDT 2025
Tue Jun 17 22:35:43 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed false
IsScholarly true
Keywords atherosclerosis
apoptosis
cytokines
JAK/STAT
inflammation
Language English
License This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access page (https://us.sagepub.com/en-us/nam/open-access-at-sage).
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c449t-c8ed6d5499e3b7f583010e5c45bd8e466d77e3c443d8097dee4edcb10ac30a5b3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
ObjectType-Review-3
content type line 23
ORCID 0000-0002-9574-8155
OpenAccessLink https://journals.sagepub.com/doi/full/10.1177/10742484241248046?utm_source=summon&utm_medium=discovery-provider
PMID 38656132
PQID 3046518113
PQPubID 23479
ParticipantIDs doaj_primary_oai_doaj_org_article_f68c961c26c1459ea5a651e1c4233279
proquest_miscellaneous_3046518113
pubmed_primary_38656132
crossref_citationtrail_10_1177_10742484241248046
crossref_primary_10_1177_10742484241248046
sage_journals_10_1177_10742484241248046
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2024-01-01
PublicationDateYYYYMMDD 2024-01-01
PublicationDate_xml – month: 01
  year: 2024
  text: 2024-01-01
  day: 01
PublicationDecade 2020
PublicationPlace Los Angeles, CA
PublicationPlace_xml – name: Los Angeles, CA
– name: United States
PublicationTitle Journal of cardiovascular pharmacology and therapeutics
PublicationTitleAlternate J Cardiovasc Pharmacol Ther
PublicationYear 2024
Publisher SAGE Publications
SAGE Publishing
Publisher_xml – name: SAGE Publications
– name: SAGE Publishing
References Darnell, Kerr, Stark 1994; 264
Jiang, Zhao, Mao, Wang, Zheng, You 2019; 38
Fietta, Costa, Delsante 2014; 107
Whitman, Ravisankar, Elam, Daugherty 2000; 157
Michalska, Blaszczyk, Wesoly, Bluyssen 2018; 9
Kubo, Yamaoka, Kondo 2014; 73
Gharavi, Alva, Mouillesseaux 2007; 282
Grothusen, Schuett, Hillmer 2012; 7
Cao, Jia, Yan, Chen, Xing, Shen 2019; 20
Yu, Zhang, Liu, Tang, Peng, Chen 2021; 6
Goumans, Ten Dijke 2018; 10
Tanaka, Narazaki, Kishimoto 2014; 6
Grebe, Hoss, Latz 2018; 122
Pistritto, Trisciuoglio, Ceci, Garufi, D'Orazi 2016; 8
Falk 2006; 47
Wang, Gao, Shi 2017; 547
2022; 21
Miao, Zang, Cui, Zhang 2020; 1207
Ridker, Libby, MacFadyen 2018; 39
Tipping, Hancock 1993; 142
Fu, Sun, Long 2022; 105
Schieffer, Selle, Hilfiker 2004; 110
Cai, Cai, Luo, Chen, Zhang 2015; 38
Zhang, Boisson-Dupuis, Chapgier 2008; 226
Basatemur, Jorgensen, Clarke, Bennett, Mallat 2019; 16
Guo, Zhou, Xie 2022; 155
Cagnina, Chabot, Davin 2022; 77
Elmore 2007; 35
Prabhu, Bhat, Siveen 2021; 144
Cooney 2002; 17
Libby, Buring, Badimon 2019; 5
Pietrocola, Izzo, Niso-Santano 2013; 23
Zhu, Jian, Zhong 2021; 12
Ortiz-Munoz, Martin-Ventura, Hernandez-Vargas 2009; 29
McLornan, Pope, Gotlib, Harrison 2021; 398
Heiser, Labi, Erlacher, Villunger 2004; 39
Li, Huang, Zhao, Yan, Lu 2020; 16
Grote, Luchtefeld, Schieffer 2005; 43
Borras, Mas-Bargues, Roman-Dominguez 2020; 21
Munjal, Khandia 2020; 120
Bakhshi, Wright, Graninger 1987; 84
Wang, Wang, Wang, Yun, Wang, Wang 2017; 490
Lu, Stump, Wallace 2011; 187
Shao, Han, Zeng, Su, Liu 2016; 37
Li, Liu, Chen 2006; 344
Baldini, Moriconi, Galimberti, Libby, De Caterina 2021; 42
Zhang, Huang, Li 2012; 528
Kim, Oh, Park 2021; 35
Taleb, Romain, Ramkhelawon 2009; 206
Xin, Xu, Deng 2020; 80
Liang, He, Chen 2013; 31
Ridker, Rane 2021; 128
Biros, Reznik, Moran 2022; 32
Banerjee, Biehl, Gadina, Hasni, Schwartz 2017; 77
Yao, Jin, Zheng 2022; 8
Xu, Ye 2022; 11
Hu, Li, Fu, Zhao, Wang 2021; 6
Kelley, Jeltema, Duan, He 2019; 20
Mackesy, Goalstone 2011; 8
Kim, Shin, Chung, Lee, Baek, Lee 2019; 8
Kamtchum-Tatuene, Saba, Heldner 2022; 131
Wei, Lan, Zheng 2023; 14
Spitz, Gavathiotis 2022; 43
Boise, Gonzalez-Garcia, Postema 1993; 74
Shi, Zhao, Wang 2015; 526
Stephanou, Latchman 2003; 84
Hu, Liu, Zhang 2022; 111
Morikawa, Derynck, Miyazono 2016; 8
Wang, Zhao, Wang, Wang, Liu, Zhang 2021; 100
Zhao, Ou, Wang, Yan, Chi 2017; 9
Barrett, Schlegel, Zhou 2019; 11
Huang, Li, Zhang 2020; 24
Tubaro, Guido, Sciarra, Mustilli, Carbone, D'Errico 2000; 15
Parzych, Klionsky 2014; 20
Liu, Zhang, Wang 2022; 13
Zhang, Alcaide, Liu 2011; 6
Georgakis, Malik, Li 2021; 143
Bian, Jing, Yang 2020; 12
Idriss, Naismith 2000; 50
Grainger 2007; 74
Li, Zhao, Shi 2015; 36
Gao, Liu, Yuan 2016; 20
Ogata, Chinen, Yoshida 2006; 25
Heinrich, Behrmann, Haan, Hermanns, Muller-Newen, Schaper 2003; 374
Chen, Qin, Li 2019; 1
Bjorkegren, Lusis 2022; 185
Xu, Lai, Hua 2019; 39
McDonnell 1993; 8
Grootaert, Moulis, Roth 2018; 114
Recio, Oguiza, Lazaro, Mallavia, Egido, Gomez-Guerrero 2014; 34
Xu, Li, Wang, Cao 2022; 148
Traves, Murray, Campigotto, Galien, Meng, Di Paolo 2021; 80
Philips, Wang, Cheon 2022; 185
Xu, Zheng, Hu, Wang 2018; 476
Ridker PM (bibr25-10742484241248046) 2018; 39
Ridker PM (bibr31-10742484241248046) 2021; 128
Jiang L (bibr75-10742484241248046) 2019; 38
Barrett TJ (bibr20-10742484241248046) 2019; 11
Kim CW (bibr47-10742484241248046) 2021; 35
Zhang SY (bibr34-10742484241248046) 2008; 226
Baldini C (bibr8-10742484241248046) 2021; 42
Yu P (bibr79-10742484241248046) 2021; 6
Banerjee S (bibr9-10742484241248046) 2017; 77
Liang X (bibr16-10742484241248046) 2013; 31
Whitman SC (bibr36-10742484241248046) 2000; 157
Michalska A (bibr38-10742484241248046) 2018; 9
Cao H (bibr69-10742484241248046) 2019; 20
Cooney RN (bibr14-10742484241248046) 2002; 17
Morikawa M (bibr52-10742484241248046) 2016; 8
Basatemur GL (bibr61-10742484241248046) 2019; 16
Tanaka T (bibr23-10742484241248046) 2014; 6
Kelley N (bibr85-10742484241248046) 2019; 20
Kubo S (bibr41-10742484241248046) 2014; 73
Munjal A (bibr24-10742484241248046) 2020; 120
Gao W (bibr46-10742484241248046) 2016; 20
Borras C (bibr64-10742484241248046) 2020; 21
Pietrocola F (bibr92-10742484241248046) 2013; 23
Spitz AZ (bibr72-10742484241248046) 2022; 43
Li HX (bibr6-10742484241248046) 2015; 36
Parzych KR (bibr88-10742484241248046) 2014; 20
McLornan DP (bibr94-10742484241248046) 2021; 398
Wei Y (bibr84-10742484241248046) 2023; 14
Huang W (bibr78-10742484241248046) 2020; 24
Falk E (bibr93-10742484241248046) 2006; 47
Traves PG (bibr32-10742484241248046) 2021; 80
Wang L (bibr51-10742484241248046) 2021; 100
Bjorkegren JLM (bibr1-10742484241248046) 2022; 185
Hu L (bibr49-10742484241248046) 2022; 111
Li D (bibr58-10742484241248046) 2006; 344
Yao F (bibr83-10742484241248046) 2022; 8
Cai B (bibr13-10742484241248046) 2015; 38
Fietta P (bibr21-10742484241248046) 2014; 107
Heinrich PC (bibr30-10742484241248046) 2003; 374
Chen PY (bibr54-10742484241248046) 2019; 1
Miao J (bibr89-10742484241248046) 2020; 1207
Kim TW (bibr50-10742484241248046) 2019; 8
Xu F (bibr76-10742484241248046) 2022; 148
Xu YJ (bibr80-10742484241248046) 2018; 476
McDonnell TJ (bibr66-10742484241248046) 1993; 8
Tubaro M (bibr48-10742484241248046) 2000; 15
Guo S (bibr56-10742484241248046) 2022; 155
Mackesy DZ (bibr44-10742484241248046) 2011; 8
Gharavi NM (bibr12-10742484241248046) 2007; 282
Zhu H (bibr87-10742484241248046) 2021; 12
Bakhshi A (bibr65-10742484241248046) 1987; 84
Philips RL (bibr7-10742484241248046) 2022; 185
Tipping PG (bibr45-10742484241248046) 1993; 142
Georgakis MK (bibr26-10742484241248046) 2021; 143
(bibr55-10742484241248046) 2022; 21
Stephanou A (bibr74-10742484241248046) 2003; 84
Li J (bibr22-10742484241248046) 2020; 16
Idriss HT (bibr43-10742484241248046) 2000; 50
Grothusen C (bibr17-10742484241248046) 2012; 7
Fu X (bibr11-10742484241248046) 2022; 105
Zhang J (bibr35-10742484241248046) 2011; 6
Liu W (bibr40-10742484241248046) 2022; 13
Wang Z (bibr33-10742484241248046) 2017; 490
Grote K (bibr5-10742484241248046) 2005; 43
Ogata H (bibr59-10742484241248046) 2006; 25
Cagnina A (bibr3-10742484241248046) 2022; 77
Goumans MJ (bibr53-10742484241248046) 2018; 10
Shi J (bibr81-10742484241248046) 2015; 526
Grebe A (bibr86-10742484241248046) 2018; 122
Libby P (bibr2-10742484241248046) 2019; 5
Zhao J (bibr71-10742484241248046) 2017; 9
Kamtchum-Tatuene J (bibr27-10742484241248046) 2022; 131
Xu Y (bibr67-10742484241248046) 2022; 11
Biros E (bibr37-10742484241248046) 2022; 32
Ortiz-Munoz G (bibr15-10742484241248046) 2009; 29
Prabhu KS (bibr77-10742484241248046) 2021; 144
Shao BZ (bibr90-10742484241248046) 2016; 37
Boise LH (bibr68-10742484241248046) 1993; 74
Hu X (bibr10-10742484241248046) 2021; 6
Darnell JE (bibr39-10742484241248046) 1994; 264
Recio C (bibr18-10742484241248046) 2014; 34
Grootaert MOJ (bibr91-10742484241248046) 2018; 114
Wang Y (bibr82-10742484241248046) 2017; 547
Pistritto G (bibr73-10742484241248046) 2016; 8
Zhang K (bibr28-10742484241248046) 2012; 528
Xu X (bibr60-10742484241248046) 2019; 39
Schieffer B (bibr29-10742484241248046) 2004; 110
Heiser D (bibr63-10742484241248046) 2004; 39
Bian W (bibr70-10742484241248046) 2020; 12
Taleb S (bibr19-10742484241248046) 2009; 206
Lu LD (bibr42-10742484241248046) 2011; 187
Xin P (bibr4-10742484241248046) 2020; 80
Grainger DJ (bibr57-10742484241248046) 2007; 74
Elmore S (bibr62-10742484241248046) 2007; 35
References_xml – volume: 8
  issue: 10
  year: 2019
  article-title: Anti-inflammatory mechanisms of Koreanaside A, a Lignan isolated from the flower of Forsythia koreana, against LPS-induced macrophage activation and DSS-induced colitis mice: the crucial role of AP-1, NF-kappaB, and JAK/STAT signaling
  publication-title: Cells
– volume: 9
  start-page: 1135
  year: 2018
  article-title: A positive feedback amplifier circuit that regulates interferon (IFN)-stimulated gene expression and controls type I and type II IFN responses
  publication-title: Front Immunol
– volume: 547
  start-page: 99
  issue: 7661
  year: 2017
  end-page: 103
  article-title: Chemotherapy drugs induce pyroptosis through caspase-3 cleavage of a gasdermin
  publication-title: Nature
– volume: 131
  issue: 2
  year: 2022
  end-page: e33
  article-title: Interleukin-6 predicts carotid plaque severity, vulnerability, and progression
  publication-title: Circ Res
– volume: 74
  start-page: 597
  issue: 4
  year: 1993
  end-page: 608
  article-title: bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death
  publication-title: Cell
– volume: 142
  start-page: 1721
  issue: 6
  year: 1993
  end-page: 1728
  article-title: Production of tumor necrosis factor and interleukin-1 by macrophages from human atheromatous plaques
  publication-title: Am J Pathol
– volume: 43
  start-page: 357
  issue: 5
  year: 2005
  end-page: 363
  article-title: JANUS under stress–role of JAK/STAT signaling pathway in vascular diseases
  publication-title: Vascul Pharmacol
– volume: 39
  start-page: 1125
  issue: 8
  year: 2004
  end-page: 1135
  article-title: The Bcl-2 protein family and its role in the development of neoplastic disease
  publication-title: Exp Gerontol
– volume: 77
  start-page: 302
  issue: 5-6
  year: 2022
  end-page: 309
  article-title: Atherosclerosis, an inflammatory disease
  publication-title: Rev Med Liege
– volume: 80
  start-page: 106210
  year: 2020
  article-title: The role of JAK/STAT signaling pathway and its inhibitors in diseases
  publication-title: Int Immunopharmacol
– volume: 17
  start-page: 83
  issue: 2
  year: 2002
  end-page: 90
  article-title: Suppressors of cytokine signaling (SOCS): inhibitors of the JAK/STAT pathway
  publication-title: Shock
– volume: 5
  start-page: 56
  issue: 1
  year: 2019
  article-title: Atherosclerosis
  publication-title: Nat Rev Dis Primers
– volume: 13
  start-page: 954706
  year: 2022
  article-title: IFN-gamma, should not be ignored in SLE
  publication-title: Front Immunol
– volume: 35
  issue: 3
  year: 2021
  article-title: A strategy to prevent atherosclerosis via TNF receptor regulation
  publication-title: FASEB J
– volume: 73
  start-page: 2192
  issue: 12
  year: 2014
  end-page: 2198
  article-title: The JAK inhibitor, tofacitinib, reduces the T cell stimulatory capacity of human monocyte-derived dendritic cells
  publication-title: Ann Rheum Dis
– volume: 120
  start-page: 85
  year: 2020
  end-page: 122
  article-title: Atherosclerosis: orchestrating cells and biomolecules involved in its activation and inhibition
  publication-title: Adv Protein Chem Struct Biol
– volume: 50
  start-page: 184
  issue: 3
  year: 2000
  end-page: 195
  article-title: TNF Alpha and the TNF receptor superfamily: structure-function relationship(s)
  publication-title: Microsc Res Tech
– volume: 74
  start-page: 213
  issue: 2
  year: 2007
  end-page: 222
  article-title: TGF-beta and atherosclerosis in man
  publication-title: Cardiovasc Res
– volume: 24
  start-page: 13949
  issue: 23
  year: 2020
  end-page: 13960
  article-title: IGF2BP3 facilitates cell proliferation and tumorigenesis via modulation of JAK/STAT signalling pathway in human bladder cancer
  publication-title: J Cell Mol Med
– volume: 42
  start-page: 4389
  issue: 42
  year: 2021
  end-page: 4400
  article-title: The JAK-STAT pathway: an emerging target for cardiovascular disease in rheumatoid arthritis and myeloproliferative neoplasms
  publication-title: Eur Heart J
– volume: 1207
  start-page: 237
  year: 2020
  end-page: 264
  article-title: Autophagy, hyperlipidemia, and atherosclerosis
  publication-title: Adv Exp Med Biol
– volume: 43
  start-page: 206
  issue: 3
  year: 2022
  end-page: 220
  article-title: Physiological and pharmacological modulation of BAX
  publication-title: Trends Pharmacol Sci
– volume: 8
  issue: 5
  year: 2016
  article-title: TGF-beta and the TGF-beta family: context-dependent roles in cell and tissue physiology
  publication-title: Cold Spring Harb Perspect Biol
– volume: 6
  start-page: 128
  issue: 1
  year: 2021
  article-title: Pyroptosis: mechanisms and diseases
  publication-title: Signal Transduct Target Ther
– volume: 344
  start-page: 701
  issue: 3
  year: 2006
  end-page: 707
  article-title: Suppression of atherogenesis by delivery of TGFbeta1ACT using adeno-associated virus type 2 in LDLR knockout mice
  publication-title: Biochem Biophys Res Commun
– volume: 155
  start-page: 113775
  year: 2022
  article-title: Resveratrol inhibiting TGF/ERK signaling pathway can improve atherosclerosis: backgrounds, mechanisms and effects
  publication-title: Biomed Pharmacother
– volume: 8
  start-page: 34
  year: 2011
  article-title: Insulin augments tumor necrosis factor-alpha stimulated expression of vascular cell adhesion molecule-1 in vascular endothelial cells
  publication-title: J Inflamm (Lond)
– volume: 20
  start-page: 3328
  issue: 13
  year: 2019
  article-title: The NLRP3 inflammasome: an overview of mechanisms of activation and regulation
  publication-title: Int J Mol Sci
– volume: 8
  start-page: 209
  issue: 4
  year: 1993
  end-page: 213
  article-title: Cell division versus cell death: a functional model of multistep neoplasia
  publication-title: Mol Carcinog
– volume: 77
  start-page: 521
  issue: 5
  year: 2017
  end-page: 546
  article-title: JAK-STAT signaling as a target for inflammatory and autoimmune diseases: current and future prospects
  publication-title: Drugs
– volume: 25
  start-page: 2520
  issue: 17
  year: 2006
  end-page: 2530
  article-title: Loss of SOCS3 in the liver promotes fibrosis by enhancing STAT3-mediated TGF-beta1 production
  publication-title: Oncogene
– volume: 185
  start-page: 1630
  issue: 10
  year: 2022
  end-page: 1645
  article-title: Atherosclerosis: recent developments
  publication-title: Cell
– volume: 12
  start-page: 714943
  year: 2021
  article-title: Janus kinase inhibition ameliorates ischemic stroke injury and neuroinflammation through reducing NLRP3 inflammasome activation via JAK2/STAT3 pathway inhibition
  publication-title: Front Immunol
– volume: 16
  start-page: 727
  issue: 12
  year: 2019
  end-page: 744
  article-title: Vascular smooth muscle cells in atherosclerosis
  publication-title: Nat Rev Cardiol
– volume: 11
  start-page: 31
  issue: 1
  year: 2022
  article-title: Progress in understanding the mechanisms of resistance to BCL-2 inhibitors
  publication-title: Exp Hematol Oncol
– volume: 100
  start-page: 108117
  year: 2021
  article-title: FPS-ZM1 inhibits LPS-induced microglial inflammation by suppressing JAK/STAT signaling pathway
  publication-title: Int Immunopharmacol
– volume: 20
  issue: 23
  year: 2019
  article-title: Quercetin suppresses the progression of atherosclerosis by regulating MST1-mediated autophagy in ox-LDL-induced RAW264.7 macrophage foam cells
  publication-title: Int J Mol Sci
– volume: 122
  start-page: 1722
  issue: 12
  year: 2018
  end-page: 1740
  article-title: NLRP3 inflammasome and the IL-1 pathway in atherosclerosis
  publication-title: Circ Res
– volume: 107
  start-page: 13
  issue: 1-2
  year: 2014
  end-page: 45
  article-title: Interleukins (ILs), a fascinating family of cytokines. Part I: ILs from IL-1 to IL-19
  publication-title: Theor Biol Forum
– volume: 490
  start-page: 194
  issue: 2
  year: 2017
  end-page: 201
  article-title: Tofacitinib ameliorates atherosclerosis and reduces foam cell formation in apoE deficient mice
  publication-title: Biochem Biophys Res Commun
– volume: 144
  start-page: 112358
  year: 2021
  article-title: Sanguinarine mediated apoptosis in non-small cell lung cancer via generation of reactive oxygen species and suppression of JAK/STAT pathway
  publication-title: Biomed Pharmacother
– volume: 11
  issue: 517
  year: 2019
  article-title: Platelet regulation of myeloid suppressor of cytokine signaling 3 accelerates atherosclerosis
  publication-title: Sci Transl Med
– volume: 23
  start-page: 310
  issue: 5
  year: 2013
  end-page: 322
  article-title: Regulation of autophagy by stress-responsive transcription factors
  publication-title: Semin Cancer Biol
– volume: 110
  start-page: 3493
  issue: 22
  year: 2004
  end-page: 3500
  article-title: Impact of interleukin-6 on plaque development and morphology in experimental atherosclerosis
  publication-title: Circulation
– volume: 143
  start-page: 1177
  issue: 11
  year: 2021
  end-page: 1180
  article-title: Genetically downregulated interleukin-6 signaling is associated with a favorable cardiometabolic profile: a phenome-wide association study
  publication-title: Circulation
– volume: 157
  start-page: 1819
  issue: 6
  year: 2000
  end-page: 1824
  article-title: Exogenous interferon-gamma enhances atherosclerosis in apolipoprotein E-/- mice
  publication-title: Am J Pathol
– volume: 80
  start-page: 865
  issue: 7
  year: 2021
  end-page: 875
  article-title: JAK Selectivity and the implications for clinical inhibition of pharmacodynamic cytokine signalling by filgotinib, upadacitinib, tofacitinib and baricitinib
  publication-title: Ann Rheum Dis
– volume: 15
  start-page: 108
  issue: 1
  year: 2000
  end-page: 114
  article-title: Atherosclerosis and simvastatin: new questions for the new millennium
  publication-title: Ann Ital Med Int
– volume: 105
  start-page: 154385
  year: 2022
  article-title: Glycosides from buyang huanwu decoction inhibit atherosclerotic inflammation via JAK/STAT signaling pathway
  publication-title: Phytomedicine
– volume: 29
  start-page: 525
  issue: 4
  year: 2009
  end-page: 531
  article-title: Suppressors of cytokine signaling modulate JAK/STAT-mediated cell responses during atherosclerosis
  publication-title: Arterioscler Thromb Vasc Biol
– volume: 6
  issue: 10
  year: 2014
  article-title: IL-6 in inflammation, immunity, and disease
  publication-title: Cold Spring Harb Perspect Biol
– volume: 8
  start-page: 112
  issue: 1
  year: 2022
  article-title: HDAC11 promotes both NLRP3/caspase-1/GSDMD and caspase-3/GSDME pathways causing pyroptosis via ERG in vascular endothelial cells
  publication-title: Cell Death Discov
– volume: 398
  start-page: 803
  issue: 10302
  year: 2021
  end-page: 816
  article-title: Current and future status of JAK inhibitors
  publication-title: Lancet
– volume: 16
  start-page: 2323
  issue: 13
  year: 2020
  end-page: 2339
  article-title: The role of interleukins in colorectal cancer
  publication-title: Int J Biol Sci
– volume: 39
  issue: 1
  year: 2019
  article-title: Apoptosis and apoptotic body: disease message and therapeutic target potentials
  publication-title: Biosci Rep
– volume: 12
  start-page: 6385
  issue: 7
  year: 2020
  end-page: 6400
  article-title: Downregulation of LncRNA NORAD promotes Ox-LDL-induced vascular endothelial cell injury and atherosclerosis
  publication-title: Aging (Albany NY)
– volume: 32
  start-page: 138
  issue: 3
  year: 2022
  end-page: 142
  article-title: Role of inflammatory cytokines in genesis and treatment of atherosclerosis
  publication-title: Trends Cardiovasc Med
– volume: 526
  start-page: 660
  issue: 7575
  year: 2015
  end-page: 665
  article-title: Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death
  publication-title: Nature
– volume: 38
  start-page: 1599
  issue: 4
  year: 2015
  end-page: 1608
  article-title: The specific roles of JAK/STAT signaling pathway in sepsis
  publication-title: Inflammation
– volume: 6
  start-page: 402
  issue: 1
  year: 2021
  article-title: The JAK/STAT signaling pathway: from bench to clinic
  publication-title: Signal Transduct Target Ther
– volume: 282
  start-page: 31460
  issue: 43
  year: 2007
  end-page: 8
  article-title: Role of the Jak/STAT pathway in the regulation of interleukin-8 transcription by oxidized phospholipids in vitro and in atherosclerosis in vivo
  publication-title: J Biol Chem
– volume: 206
  start-page: 2067
  issue: 10
  year: 2009
  end-page: 2077
  article-title: Loss of SOCS3 expression in T cells reveals a regulatory role for interleukin-17 in atherosclerosis
  publication-title: J Exp Med
– volume: 185
  start-page: 3857
  issue: 21
  year: 2022
  end-page: 3876
  article-title: The JAK-STAT pathway at 30: much learned, much more to do
  publication-title: Cell
– volume: 111
  start-page: 109095
  year: 2022
  article-title: Advance in bone destruction participated by JAK/STAT in rheumatoid arthritis and therapeutic effect of JAK/STAT inhibitors
  publication-title: Int Immunopharmacol
– volume: 9
  start-page: 3433
  issue: 7
  year: 2017
  end-page: 3442
  article-title: MicroRNA-1907 enhances atherosclerosis-associated endothelial cell apoptosis by suppressing Bcl-2
  publication-title: Am J Transl Res
– volume: 7
  issue: 12
  year: 2012
  article-title: Role of suppressor of cytokine signaling-1 in murine atherosclerosis
  publication-title: PLoS One
– volume: 528
  start-page: 127
  issue: 2
  year: 2012
  end-page: 133
  article-title: Interleukin 6 destabilizes atherosclerotic plaques by downregulating prolyl-4-hydroxylase alpha1 via a mitogen-activated protein kinase and c-Jun pathway
  publication-title: Arch Biochem Biophys
– volume: 37
  start-page: 150
  issue: 2
  year: 2016
  end-page: 156
  article-title: The roles of macrophage autophagy in atherosclerosis
  publication-title: Acta Pharmacol Sin
– volume: 187
  start-page: 3840
  issue: 7
  year: 2011
  end-page: 3853
  article-title: Depletion of autoreactive plasma cells and treatment of lupus nephritis in mice using CEP-33779, a novel, orally active, selective inhibitor of JAK2
  publication-title: J Immunol
– volume: 8
  start-page: 603
  issue: 4
  year: 2016
  end-page: 619
  article-title: Apoptosis as anticancer mechanism: function and dysfunction of its modulators and targeted therapeutic strategies
  publication-title: Aging (Albany NY)
– volume: 476
  start-page: 28
  year: 2018
  end-page: 37
  article-title: Pyroptosis and its relationship to atherosclerosis
  publication-title: Clin Chim Acta
– volume: 39
  start-page: 3499
  issue: 38
  year: 2018
  end-page: 3507
  article-title: Modulation of the interleukin-6 signalling pathway and incidence rates of atherosclerotic events and all-cause mortality: analyses from the canakinumab anti-inflammatory thrombosis outcomes study (CANTOS)
  publication-title: Eur Heart J
– volume: 31
  start-page: 1066
  issue: 5
  year: 2013
  end-page: 1074
  article-title: Multiple roles of SOCS proteins: differential expression of SOCS1 and SOCS3 in atherosclerosis
  publication-title: Int J Mol Med
– volume: 36
  start-page: 8671
  issue: 11
  year: 2015
  end-page: 8678
  article-title: Retinoic acid amide inhibits JAK/STAT pathway in lung cancer which leads to apoptosis
  publication-title: Tumour Biol
– volume: 6
  issue: 1
  year: 2011
  article-title: Regulation of endothelial cell adhesion molecule expression by mast cells, macrophages, and neutrophils
  publication-title: PLoS One
– volume: 20
  start-page: 460
  issue: 3
  year: 2014
  end-page: 473
  article-title: An overview of autophagy: morphology, mechanism, and regulation
  publication-title: Antioxid Redox Signal
– volume: 35
  start-page: 495
  issue: 4
  year: 2007
  end-page: 516
  article-title: Apoptosis: a review of programmed cell death
  publication-title: Toxicol Pathol
– volume: 21
  issue: 2
  year: 2020
  article-title: BCL-xL, a mitochondrial protein involved in successful aging: from C. elegans to human centenarians
  publication-title: Int J Mol Sci
– volume: 226
  start-page: 29
  issue: 1
  year: 2008
  end-page: 40
  article-title: Inborn errors of interferon (IFN)-mediated immunity in humans: insights into the respective roles of IFN-alpha/beta, IFN-gamma, and IFN-lambda in host defense
  publication-title: Immunol Rev
– volume: 34
  start-page: 1953
  issue: 9
  year: 2014
  end-page: 1960
  article-title: Suppressor of cytokine signaling 1-derived peptide inhibits Janus kinase/signal transducers and activators of transcription pathway and improves inflammation and atherosclerosis in diabetic mice
  publication-title: Arterioscler Thromb Vasc Biol
– volume: 20
  start-page: 2318
  issue: 12
  year: 2016
  end-page: 2327
  article-title: Exosomes derived from mature dendritic cells increase endothelial inflammation and atherosclerosis via membrane TNF-alpha mediated NF-kappaB pathway
  publication-title: J Cell Mol Med
– volume: 84
  start-page: 2396
  issue: 8
  year: 1987
  end-page: 2400
  article-title: Mechanism of the t(14;18) chromosomal translocation: structural analysis of both derivative 14 and 18 reciprocal partners
  publication-title: Proc Natl Acad Sci U S A
– volume: 128
  start-page: 1728
  issue: 11
  year: 2021
  end-page: 1746
  article-title: Interleukin-6 signaling and anti-interleukin-6 therapeutics in cardiovascular disease
  publication-title: Circ Res
– volume: 38
  start-page: 465
  issue: 1
  year: 2019
  article-title: Long non-coding RNA RP11-468E2.5 curtails colorectal cancer cell proliferation and stimulates apoptosis via the JAK/STAT signaling pathway by targeting STAT5 and STAT6
  publication-title: J Exp Clin Cancer Res
– volume: 264
  start-page: 1415
  issue: 5164
  year: 1994
  end-page: 1421
  article-title: Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins
  publication-title: Science
– volume: 1
  start-page: 912
  issue: 9
  year: 2019
  end-page: 926
  article-title: Endothelial TGF-beta signalling drives vascular inflammation and atherosclerosis
  publication-title: Nat Metab
– volume: 114
  start-page: 622
  issue: 4
  year: 2018
  end-page: 634
  article-title: Vascular smooth muscle cell death, autophagy and senescence in atherosclerosis
  publication-title: Cardiovasc Res
– volume: 84
  start-page: 239
  issue: 6
  year: 2003
  end-page: 244
  article-title: STAT-1: a novel regulator of apoptosis
  publication-title: Int J Exp Pathol
– volume: 148
  start-page: 112781
  year: 2022
  article-title: Retraction notice to “Sinomenine inhibits proliferation, migration, invasion and promotes apoptosis of prostate cancer cells by regulation of miR-23a” [Biomed. Pharmacother. 112 (2019) 108592]
  publication-title: Biomed Pharmacother
– volume: 10
  issue: 2
  year: 2018
  article-title: TGF-beta signaling in control of cardiovascular function
  publication-title: Cold Spring Harb Perspect Biol
– volume: 47
  issue: 8 Suppl
  year: 2006
  end-page: 12
  article-title: Pathogenesis of atherosclerosis
  publication-title: J Am Coll Cardiol
– volume: 14
  start-page: 929
  issue: 1
  year: 2023
  article-title: GSDME-mediated pyroptosis promotes the progression and associated inflammation of atherosclerosis
  publication-title: Nat Commun
– volume: 374
  start-page: 1
  issue: Pt 1
  year: 2003
  end-page: 20
  article-title: Principles of interleukin (IL)-6-type cytokine signalling and its regulation
  publication-title: Biochem J
– volume: 21
  start-page: 1437
  issue: 13
  year: 2022
  article-title: Statement of retraction: 1,25(OH)2D3 improves blood lipid metabolism, liver function, and atherosclerosis by constraining the TGF-beta/Smad signaling pathway in rats with hyperlipidemia
  publication-title: Cell Cycle
– volume: 5
  start-page: 56
  issue: 1
  year: 2019
  ident: bibr2-10742484241248046
  publication-title: Nat Rev Dis Primers
  doi: 10.1038/s41572-019-0106-z
– volume: 100
  start-page: 108117
  year: 2021
  ident: bibr51-10742484241248046
  publication-title: Int Immunopharmacol
  doi: 10.1016/j.intimp.2021.108117
– volume: 8
  start-page: 34
  year: 2011
  ident: bibr44-10742484241248046
  publication-title: J Inflamm (Lond)
  doi: 10.1186/1476-9255-8-34
– volume: 206
  start-page: 2067
  issue: 10
  year: 2009
  ident: bibr19-10742484241248046
  publication-title: J Exp Med
  doi: 10.1084/jem.20090545
– volume: 35
  issue: 3
  year: 2021
  ident: bibr47-10742484241248046
  publication-title: FASEB J
– volume: 185
  start-page: 3857
  issue: 21
  year: 2022
  ident: bibr7-10742484241248046
  publication-title: Cell
  doi: 10.1016/j.cell.2022.09.023
– volume: 374
  start-page: 1
  issue: 1
  year: 2003
  ident: bibr30-10742484241248046
  publication-title: Biochem J
  doi: 10.1042/bj20030407
– volume: 114
  start-page: 622
  issue: 4
  year: 2018
  ident: bibr91-10742484241248046
  publication-title: Cardiovasc Res
  doi: 10.1093/cvr/cvy007
– volume: 528
  start-page: 127
  issue: 2
  year: 2012
  ident: bibr28-10742484241248046
  publication-title: Arch Biochem Biophys
  doi: 10.1016/j.abb.2012.09.007
– volume: 1207
  start-page: 237
  year: 2020
  ident: bibr89-10742484241248046
  publication-title: Adv Exp Med Biol
  doi: 10.1007/978-981-15-4272-5_18
– volume: 16
  start-page: 727
  issue: 12
  year: 2019
  ident: bibr61-10742484241248046
  publication-title: Nat Rev Cardiol
  doi: 10.1038/s41569-019-0227-9
– volume: 264
  start-page: 1415
  issue: 5164
  year: 1994
  ident: bibr39-10742484241248046
  publication-title: Science
  doi: 10.1126/science.8197455
– volume: 16
  start-page: 2323
  issue: 13
  year: 2020
  ident: bibr22-10742484241248046
  publication-title: Int J Biol Sci
  doi: 10.7150/ijbs.46651
– volume: 120
  start-page: 85
  year: 2020
  ident: bibr24-10742484241248046
  publication-title: Adv Protein Chem Struct Biol
  doi: 10.1016/bs.apcsb.2019.11.002
– volume: 32
  start-page: 138
  issue: 3
  year: 2022
  ident: bibr37-10742484241248046
  publication-title: Trends Cardiovasc Med
  doi: 10.1016/j.tcm.2021.02.001
– volume: 187
  start-page: 3840
  issue: 7
  year: 2011
  ident: bibr42-10742484241248046
  publication-title: J Immunol
  doi: 10.4049/jimmunol.1101228
– volume: 142
  start-page: 1721
  issue: 6
  year: 1993
  ident: bibr45-10742484241248046
  publication-title: Am J Pathol
– volume: 39
  issue: 1
  year: 2019
  ident: bibr60-10742484241248046
  publication-title: Biosci Rep
– volume: 144
  start-page: 112358
  year: 2021
  ident: bibr77-10742484241248046
  publication-title: Biomed Pharmacother
  doi: 10.1016/j.biopha.2021.112358
– volume: 21
  issue: 2
  year: 2020
  ident: bibr64-10742484241248046
  publication-title: Int J Mol Sci
  doi: 10.3390/ijms21020418
– volume: 11
  issue: 517
  year: 2019
  ident: bibr20-10742484241248046
  publication-title: Sci Transl Med
  doi: 10.1126/scitranslmed.aax0481
– volume: 21
  start-page: 1437
  issue: 13
  year: 2022
  ident: bibr55-10742484241248046
  publication-title: Cell Cycle
  doi: 10.1080/15384101.2022.2066295
– volume: 84
  start-page: 2396
  issue: 8
  year: 1987
  ident: bibr65-10742484241248046
  publication-title: Proc Natl Acad Sci U S A
  doi: 10.1073/pnas.84.8.2396
– volume: 10
  issue: 2
  year: 2018
  ident: bibr53-10742484241248046
  publication-title: Cold Spring Harb Perspect Biol
– volume: 43
  start-page: 357
  issue: 5
  year: 2005
  ident: bibr5-10742484241248046
  publication-title: Vascul Pharmacol
  doi: 10.1016/j.vph.2005.08.021
– volume: 185
  start-page: 1630
  issue: 10
  year: 2022
  ident: bibr1-10742484241248046
  publication-title: Cell
  doi: 10.1016/j.cell.2022.04.004
– volume: 398
  start-page: 803
  issue: 10302
  year: 2021
  ident: bibr94-10742484241248046
  publication-title: Lancet
  doi: 10.1016/S0140-6736(21)00438-4
– volume: 143
  start-page: 1177
  issue: 11
  year: 2021
  ident: bibr26-10742484241248046
  publication-title: Circulation
  doi: 10.1161/CIRCULATIONAHA.120.052604
– volume: 24
  start-page: 13949
  issue: 23
  year: 2020
  ident: bibr78-10742484241248046
  publication-title: J Cell Mol Med
  doi: 10.1111/jcmm.16003
– volume: 12
  start-page: 714943
  year: 2021
  ident: bibr87-10742484241248046
  publication-title: Front Immunol
  doi: 10.3389/fimmu.2021.714943
– volume: 47
  issue: 8
  year: 2006
  ident: bibr93-10742484241248046
  publication-title: J Am Coll Cardiol
  doi: 10.1016/j.jacc.2005.09.068
– volume: 38
  start-page: 465
  issue: 1
  year: 2019
  ident: bibr75-10742484241248046
  publication-title: J Exp Clin Cancer Res
  doi: 10.1186/s13046-019-1428-0
– volume: 148
  start-page: 112781
  year: 2022
  ident: bibr76-10742484241248046
  publication-title: Biomed Pharmacother
  doi: 10.1016/j.biopha.2022.112781
– volume: 1
  start-page: 912
  issue: 9
  year: 2019
  ident: bibr54-10742484241248046
  publication-title: Nat Metab
  doi: 10.1038/s42255-019-0102-3
– volume: 20
  issue: 23
  year: 2019
  ident: bibr69-10742484241248046
  publication-title: Int J Mol Sci
– volume: 50
  start-page: 184
  issue: 3
  year: 2000
  ident: bibr43-10742484241248046
  publication-title: Microsc Res Tech
  doi: 10.1002/1097-0029(20000801)50:3<184::AID-JEMT2>3.0.CO;2-H
– volume: 226
  start-page: 29
  issue: 1
  year: 2008
  ident: bibr34-10742484241248046
  publication-title: Immunol Rev
  doi: 10.1111/j.1600-065X.2008.00698.x
– volume: 344
  start-page: 701
  issue: 3
  year: 2006
  ident: bibr58-10742484241248046
  publication-title: Biochem Biophys Res Commun
  doi: 10.1016/j.bbrc.2006.04.010
– volume: 14
  start-page: 929
  issue: 1
  year: 2023
  ident: bibr84-10742484241248046
  publication-title: Nat Commun
  doi: 10.1038/s41467-023-36614-w
– volume: 39
  start-page: 1125
  issue: 8
  year: 2004
  ident: bibr63-10742484241248046
  publication-title: Exp Gerontol
  doi: 10.1016/j.exger.2004.04.011
– volume: 111
  start-page: 109095
  year: 2022
  ident: bibr49-10742484241248046
  publication-title: Int Immunopharmacol
  doi: 10.1016/j.intimp.2022.109095
– volume: 37
  start-page: 150
  issue: 2
  year: 2016
  ident: bibr90-10742484241248046
  publication-title: Acta Pharmacol Sin
  doi: 10.1038/aps.2015.87
– volume: 15
  start-page: 108
  issue: 1
  year: 2000
  ident: bibr48-10742484241248046
  publication-title: Ann Ital Med Int
– volume: 84
  start-page: 239
  issue: 6
  year: 2003
  ident: bibr74-10742484241248046
  publication-title: Int J Exp Pathol
  doi: 10.1111/j.0959-9673.2003.00363.x
– volume: 105
  start-page: 154385
  year: 2022
  ident: bibr11-10742484241248046
  publication-title: Phytomedicine
  doi: 10.1016/j.phymed.2022.154385
– volume: 42
  start-page: 4389
  issue: 42
  year: 2021
  ident: bibr8-10742484241248046
  publication-title: Eur Heart J
  doi: 10.1093/eurheartj/ehab447
– volume: 157
  start-page: 1819
  issue: 6
  year: 2000
  ident: bibr36-10742484241248046
  publication-title: Am J Pathol
  doi: 10.1016/S0002-9440(10)64820-1
– volume: 476
  start-page: 28
  year: 2018
  ident: bibr80-10742484241248046
  publication-title: Clin Chim Acta
  doi: 10.1016/j.cca.2017.11.005
– volume: 7
  issue: 12
  year: 2012
  ident: bibr17-10742484241248046
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0051608
– volume: 36
  start-page: 8671
  issue: 11
  year: 2015
  ident: bibr6-10742484241248046
  publication-title: Tumour Biol
  doi: 10.1007/s13277-015-3534-8
– volume: 43
  start-page: 206
  issue: 3
  year: 2022
  ident: bibr72-10742484241248046
  publication-title: Trends Pharmacol Sci
  doi: 10.1016/j.tips.2021.11.001
– volume: 31
  start-page: 1066
  issue: 5
  year: 2013
  ident: bibr16-10742484241248046
  publication-title: Int J Mol Med
  doi: 10.3892/ijmm.2013.1323
– volume: 6
  issue: 10
  year: 2014
  ident: bibr23-10742484241248046
  publication-title: Cold Spring Harb Perspect Biol
  doi: 10.1101/cshperspect.a016295
– volume: 13
  start-page: 954706
  year: 2022
  ident: bibr40-10742484241248046
  publication-title: Front Immunol
  doi: 10.3389/fimmu.2022.954706
– volume: 8
  start-page: 112
  issue: 1
  year: 2022
  ident: bibr83-10742484241248046
  publication-title: Cell Death Discov
  doi: 10.1038/s41420-022-00906-9
– volume: 107
  start-page: 13
  issue: 1
  year: 2014
  ident: bibr21-10742484241248046
  publication-title: Theor Biol Forum
– volume: 74
  start-page: 597
  issue: 4
  year: 1993
  ident: bibr68-10742484241248046
  publication-title: Cell
  doi: 10.1016/0092-8674(93)90508-N
– volume: 6
  start-page: 128
  issue: 1
  year: 2021
  ident: bibr79-10742484241248046
  publication-title: Signal Transduct Target Ther
  doi: 10.1038/s41392-021-00507-5
– volume: 17
  start-page: 83
  issue: 2
  year: 2002
  ident: bibr14-10742484241248046
  publication-title: Shock
  doi: 10.1097/00024382-200202000-00001
– volume: 122
  start-page: 1722
  issue: 12
  year: 2018
  ident: bibr86-10742484241248046
  publication-title: Circ Res
  doi: 10.1161/CIRCRESAHA.118.311362
– volume: 490
  start-page: 194
  issue: 2
  year: 2017
  ident: bibr33-10742484241248046
  publication-title: Biochem Biophys Res Commun
  doi: 10.1016/j.bbrc.2017.06.020
– volume: 20
  start-page: 460
  issue: 3
  year: 2014
  ident: bibr88-10742484241248046
  publication-title: Antioxid Redox Signal
  doi: 10.1089/ars.2013.5371
– volume: 110
  start-page: 3493
  issue: 22
  year: 2004
  ident: bibr29-10742484241248046
  publication-title: Circulation
  doi: 10.1161/01.CIR.0000148135.08582.97
– volume: 20
  start-page: 3328
  issue: 13
  year: 2019
  ident: bibr85-10742484241248046
  publication-title: Int J Mol Sci
  doi: 10.3390/ijms20133328
– volume: 77
  start-page: 302
  issue: 5
  year: 2022
  ident: bibr3-10742484241248046
  publication-title: Rev Med Liege
– volume: 8
  start-page: 209
  issue: 4
  year: 1993
  ident: bibr66-10742484241248046
  publication-title: Mol Carcinog
  doi: 10.1002/mc.2940080402
– volume: 23
  start-page: 310
  issue: 5
  year: 2013
  ident: bibr92-10742484241248046
  publication-title: Semin Cancer Biol
  doi: 10.1016/j.semcancer.2013.05.008
– volume: 80
  start-page: 865
  issue: 7
  year: 2021
  ident: bibr32-10742484241248046
  publication-title: Ann Rheum Dis
  doi: 10.1136/annrheumdis-2020-219012
– volume: 6
  issue: 1
  year: 2011
  ident: bibr35-10742484241248046
  publication-title: PLoS One
– volume: 80
  start-page: 106210
  year: 2020
  ident: bibr4-10742484241248046
  publication-title: Int Immunopharmacol
  doi: 10.1016/j.intimp.2020.106210
– volume: 35
  start-page: 495
  issue: 4
  year: 2007
  ident: bibr62-10742484241248046
  publication-title: Toxicol Pathol
  doi: 10.1080/01926230701320337
– volume: 25
  start-page: 2520
  issue: 17
  year: 2006
  ident: bibr59-10742484241248046
  publication-title: Oncogene
  doi: 10.1038/sj.onc.1209281
– volume: 155
  start-page: 113775
  year: 2022
  ident: bibr56-10742484241248046
  publication-title: Biomed Pharmacother
  doi: 10.1016/j.biopha.2022.113775
– volume: 8
  issue: 5
  year: 2016
  ident: bibr52-10742484241248046
  publication-title: Cold Spring Harb Perspect Biol
  doi: 10.1101/cshperspect.a021873
– volume: 12
  start-page: 6385
  issue: 7
  year: 2020
  ident: bibr70-10742484241248046
  publication-title: Aging (Albany NY)
  doi: 10.18632/aging.103034
– volume: 29
  start-page: 525
  issue: 4
  year: 2009
  ident: bibr15-10742484241248046
  publication-title: Arterioscler Thromb Vasc Biol
  doi: 10.1161/ATVBAHA.108.173781
– volume: 282
  start-page: 31460
  issue: 43
  year: 2007
  ident: bibr12-10742484241248046
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M704267200
– volume: 128
  start-page: 1728
  issue: 11
  year: 2021
  ident: bibr31-10742484241248046
  publication-title: Circ Res
  doi: 10.1161/CIRCRESAHA.121.319077
– volume: 39
  start-page: 3499
  issue: 38
  year: 2018
  ident: bibr25-10742484241248046
  publication-title: Eur Heart J
  doi: 10.1093/eurheartj/ehy310
– volume: 20
  start-page: 2318
  issue: 12
  year: 2016
  ident: bibr46-10742484241248046
  publication-title: J Cell Mol Med
  doi: 10.1111/jcmm.12923
– volume: 8
  issue: 10
  year: 2019
  ident: bibr50-10742484241248046
  publication-title: Cells
– volume: 526
  start-page: 660
  issue: 7575
  year: 2015
  ident: bibr81-10742484241248046
  publication-title: Nature
  doi: 10.1038/nature15514
– volume: 9
  start-page: 3433
  issue: 7
  year: 2017
  ident: bibr71-10742484241248046
  publication-title: Am J Transl Res
– volume: 131
  issue: 2
  year: 2022
  ident: bibr27-10742484241248046
  publication-title: Circ Res
  doi: 10.1161/CIRCRESAHA.122.320877
– volume: 74
  start-page: 213
  issue: 2
  year: 2007
  ident: bibr57-10742484241248046
  publication-title: Cardiovasc Res
  doi: 10.1016/j.cardiores.2007.02.022
– volume: 8
  start-page: 603
  issue: 4
  year: 2016
  ident: bibr73-10742484241248046
  publication-title: Aging (Albany NY)
  doi: 10.18632/aging.100934
– volume: 6
  start-page: 402
  issue: 1
  year: 2021
  ident: bibr10-10742484241248046
  publication-title: Signal Transduct Target Ther
  doi: 10.1038/s41392-021-00791-1
– volume: 77
  start-page: 521
  issue: 5
  year: 2017
  ident: bibr9-10742484241248046
  publication-title: Drugs
  doi: 10.1007/s40265-017-0701-9
– volume: 38
  start-page: 1599
  issue: 4
  year: 2015
  ident: bibr13-10742484241248046
  publication-title: Inflammation
  doi: 10.1007/s10753-015-0135-z
– volume: 11
  start-page: 31
  issue: 1
  year: 2022
  ident: bibr67-10742484241248046
  publication-title: Exp Hematol Oncol
  doi: 10.1186/s40164-022-00283-0
– volume: 547
  start-page: 99
  issue: 7661
  year: 2017
  ident: bibr82-10742484241248046
  publication-title: Nature
  doi: 10.1038/nature22393
– volume: 73
  start-page: 2192
  issue: 12
  year: 2014
  ident: bibr41-10742484241248046
  publication-title: Ann Rheum Dis
  doi: 10.1136/annrheumdis-2013-203756
– volume: 34
  start-page: 1953
  issue: 9
  year: 2014
  ident: bibr18-10742484241248046
  publication-title: Arterioscler Thromb Vasc Biol
  doi: 10.1161/ATVBAHA.114.304144
– volume: 9
  start-page: 1135
  year: 2018
  ident: bibr38-10742484241248046
  publication-title: Front Immunol
  doi: 10.3389/fimmu.2018.01135
SSID ssj0003459
Score 2.3882954
SecondaryResourceType review_article
Snippet Atherosclerosis is now widely considered to be a chronic inflammatory disease, with increasing evidence suggesting that lipid alone is not the main factor...
SourceID doaj
proquest
pubmed
crossref
sage
SourceType Open Website
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 10742484241248046
SubjectTerms Animals
Anti-Inflammatory Agents - pharmacology
Anti-Inflammatory Agents - therapeutic use
Atherosclerosis - drug therapy
Atherosclerosis - metabolism
Humans
Inflammation Mediators - metabolism
Janus Kinase Inhibitors - pharmacology
Janus Kinase Inhibitors - therapeutic use
Janus Kinases - metabolism
Signal Transduction
STAT Transcription Factors - metabolism
SummonAdditionalLinks – databaseName: DOAJ: Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1La9wwEBYlh9BLadKXk6aoUFIoMbFsS5aPm7ZLktKyNA7kZmRpFBZSu603lP33mbG1m5S-Lj3YB3tsD9LI80kz-oaxV94kUhvtY-FME-fQFLHxTlGQFwrtJfGJULbFJ3V8np9eyIs7pb4oJ2ykBx4b7tArbUslbKqsyGUJRholBQiLOCBLi2HrHvq81WQq_IMzFA0xTDFsLscZYK7xQHemE0K7d7zQQNb_O4T5U3bX4HCmD9mDgBT5ZNRwi92Ddpttfgyx8G22PxtZp5cHvLrdRNUf8H0-u-WjXj5i3_A2_9xdAe88P518ODyrJhU_m18SBm8v-QxB4A-z5KZ1_GTR83e04EwJ6F_4SShhQmLTsTIPn7ccQSOvVhnq9NYJwciuRz3xPO8fs_Pp--rtcRwqLcQ2z8tFbDU45WiqCFlTeKlx2CcgbS4bpyFXyhUFZCibOZ2UhQPIwdlGJMZmiZFN9oRttF0Lzxj3wkjIdGM8oPdPXGnRBRqTeuVNY2QZsWTV8rUNNORUDeOqFoF5_JfOitib9SNfRw6OvwkfUXeuBYk-e7iARlUHo6r_ZVQRe7kyhhqHG8VQTAvddV9TIFkiKhJZxJ6OVrL-FJVPRXSURuw1mU0d_gb9n5Xd-R_K7rL7KSKtcV3oOdtYfL-GPURKi-bFMChuABnxCXo
  priority: 102
  providerName: Directory of Open Access Journals
Title The Role of JAK/STAT Signaling Pathway and Its Downstream Influencing Factors in the Treatment of Atherosclerosis
URI https://journals.sagepub.com/doi/full/10.1177/10742484241248046
https://www.ncbi.nlm.nih.gov/pubmed/38656132
https://www.proquest.com/docview/3046518113
https://doaj.org/article/f68c961c26c1459ea5a651e1c4233279
Volume 29
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1La9wwEBZpAqWX0qaPbB9BhZJCibt-SZZPxUm6JCktS-LQ3Iysx7KQtdvYS9l_3xlb3hCSlh7sgz22BmlG-jQzmiHkvZU-E1JYL9Cy9GJTJp60mqOT1yTCMswngtEW3_nxRXx6yS43SD2chXE92HzCsCrgqJusUbvRGj12TsYxRhGGsYALlicBW7zPy3ZR9ObuoaoGPkH_9HKBrm2FAZErbzje9oBshQlnoMlb2eTsR76evKO4q6_WhSliC84Rem-jt5ayLuP_fTD1VohYt2pNnpDHDm7SrJePp2TDVNvk4TfnUN8me9M-dfVqn-Y3J7GafbpHpzdJrVfPyC94Tc_qK0NrS0-zr-PzPMvp-XyGQL6a0Skgyd9yRWWl6Unb0CO0WmMU-4KeuDooSDbpy_vQeUUBedJ8CHPHv2aIResG-IT7vHlOLiZf8sNjz5Vr8FQcp62nhNFc437TRGVimYC5wzdMxazUwsSc6yQxEdBGWvhpoo2JjVZl4EsV-ZKV0QuyWdWV2SHUBpKZSJTSGoAQvk4VrKNShpZbWUqWjog_9HyhXC5zLKlxVQQuffmdwRqRj-tPfvaJPP5FfIDDuSbEHNzdg_p6VjiVLiwXKuWBCrkKQGqMZBIkygQKEGoUJsDku0EYCtBZdMTIytTLpkBvNANoFUQj8rKXknVTWIMVIFY4Ih9QbIpBIf7O7Kv_pnxNHoWAyXoL0huy2V4vzVvAVG256_Rgt7NJ_AGpiBhY
linkProvider SAGE Publications
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1Za9wwEBbtBtq-lDa9tqcKJYUSp_ZakuVH91h2c7EkDs2bkXUsC4mdxhvK_vvO2FqH0LT0wX6wR_YgzWg-aUYzhHxwKuRSSRdERpUBs2USKGcEOnltIh3HfCIYbXEoJids95Sf-qhKPAvje7DZwbAq4KidrHvtbs-Jw2KOSbjAMklY3d0lGwyt1oBsZOOjH3k_D8esLZXWRhxiC-_TvPUjN6xSm7z_NsR5I9qrNUDjR-ShR44064b6Mbljq01y78D7xjfJ1qzLQr3apvn1oapmm27R2XV-6tUT8hNe06P6zNLa0d1s7_NxnuX0eDFHTF7N6QxA4S-1oqoydLps6DfcgMaA9HM69SVNkGzcVeqhi4oCiKT5OmIdv5ohrKwb4BPui-YpORl_z79OAl95IdCMpctAS2uEwaWjjcvEcQnTQGi5Zrw00jIhTJLYGGhjI8M0MdYya3QZhUrHoeJl_IwMqrqyLwh1keI2lqVyFtBAaFINJlGpkRNOlYqnQxKue77QPi05Vsc4KyKfifyPwRqST32Tiy4nx7-Iv-Bw9oSYTrt9UF_OC6-dhRNSpyLSI6EjkBqruBI8spEGsBmPEmDy_VoYClA_9KmoytZXTYGOZQ4oKYqH5HknJf2vsJwqoKXRkHxEsSnWsv13Zl_-N-U7cn-SH-wX-9PDvVfkwQigVrcx9JoMlpdX9g1ApWX51uvEbxEOBMw
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3db9MwELegkyZeEIyvji8joSGhhebDdpzHwKjWDaZqy8TeIscfVaWRbEsn1P-eu8TtNDEQD8lDck5O9p3vZ9_5jpD3ToVcKumCyKgqYLZKA-WMQCevTaXjmE8Eoy2OxP4pOzjjZ37DDc_C-B5sP2FYFXDUTdao3RfGjbyPcYRBhDGTcIF1krDCu082GAPbOCAb-fj4R7GeixPWlUvrog6xhfdr3vmRW5apS-B_F-q8FfHVGaHxI_LQo0ea98P9mNyz9RbZ_O7941tkZ9pnol7u0uLmYFW7S3fo9CZH9fIJuYTX9Lg5t7Rx9CA_HJ0UeUFP5jPE5fWMTgEY_lJLqmpDJ4uW7uEmNAal_6QTX9YEycZ9tR46rykASVqsotbxqzlCy6YFPuE-b5-S0_HX4st-4KsvBJqxbBFoaY0wuHy0SZU6LmEqCC3XjFdGWiaESVObAG1iZJilxlpmja6iUOkkVLxKnpFB3dT2BaEuUtwmslLOAiIITabBLCoVO-FUpXg2JOGq50vtU5NjhYzzMvLZyP8YrCH5uG5y0efl-BfxZxzONSGm1O4eNFez0mto6YTUmYh0LHQEUmMVV4JHNtIAOJM4BSbfrYShBBVEv4qqbXPdluhc5oCUomRInvdSsv4VllQFxBQPyQcUm3Il339ndvu_Kd-SzeneuPw2OTp8SR7EgLb6vaFXZLC4uravAS0tqjdeJX4DCsAF3A
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+Role+of+JAK%2FSTAT+Signaling+Pathway+and+Its+Downstream+Influencing+Factors+in+the+Treatment+of+Atherosclerosis&rft.jtitle=Journal+of+cardiovascular+pharmacology+and+therapeutics&rft.au=Zhang%2C+Xin&rft.au=Chen%2C+Suwen&rft.au=Yin%2C+Guoliang&rft.au=Liang%2C+Pengpeng&rft.date=2024-01-01&rft.pub=SAGE+Publications&rft.issn=1074-2484&rft.eissn=1940-4034&rft.volume=29&rft_id=info:doi/10.1177%2F10742484241248046&rft.externalDocID=10.1177_10742484241248046
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1074-2484&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1074-2484&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1074-2484&client=summon